[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$gubra
Insights #
- $gubra engagements hit XXXXX which is XXX% higher than it's daily average.
- $gubra sentiment is up XXX% from the previous week.
- $gubra engagements is up XXXXXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXX
1 Week: XXXXX +125%
1 Month: XXXXX -XX%
1-Year High: XXXXXX on 2025-07-15
1-Year Low: X on 2025-05-25
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: XX on 2025-08-08
1-Year Low: X on 2025-04-28
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $gubra in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-05-08
1-Year Low: X on 2025-04-28
The most influential creators that mention $gubra in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @KNielsen2000 | X | XXXXX | X | XXXXX |
Sentiment: % #
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-05-08
1-Year Low: XX% on 2025-08-29
Top assets mentioned In the posts about $gubra in the last XX hours
Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Viking Therapeutics, Inc (VKTX)
Top topics mentioned In the posts about $gubra in the last XX hours
stocks healthcare, $nvo, eli lilly, $zeal, $lly, $rhhby, argentina, $vktx, market cap, has been
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$NVO launching Wegovy in Argentina Seems like they have more focus at teenagers in the launch. Sad to read XX% of teenagers in Argentina are obese. Wegovy is approved down to XX years. (Normal from XX years) and they have ongoing trials down to X years. $LLY $VKTX $GUBRA $ZEAL"
X Link @ResearchPulse1 2025-10-14T18:11Z 1492 followers, 1980 engagements
"$NVO launching Wegovy in Argentina Seems like they have more focus at teenagers in the launch. Sad to read XX% of teenagers in Argentina are obese. $LLY $VKTX $GUBRA $ZEAL"
X Link @ResearchPulse1 2025-10-14T17:53Z 1481 followers, 1216 engagements
"Obesity and MASH BD has been dominant in biotech this year with X large deals ( $RhhBY $Zeal $ABBV $GUBRA $AKRO $ETNB $NVO). Also $PFE recent deal with $MTSR could have generated confusion on what works best in terms of efficacy / tolerability balance. Wanted below to remind re mechanism performance with $NVO Redefine ( GLP1+ amylin ) vs $LLY Surmount ( tirzepatide) comparison ( same placebo performance ) . Remember tirzepatide was used alone in surmount and could be combined with amylin ( although unnecessary ) From Metsera doc Pfizer offered initially $XX for GLP1 / Amylin assets ( in phase"
X Link @bioinvestor24 2025-10-11T22:19Z 4380 followers, 5591 engagements
"6/6 Analysis of oral P2 with VK2735 $LLY $NVO $ZEAL $GUBRA $VKTX"
X Link @ResearchPulse1 2025-10-01T10:29Z 1462 followers, 1388 engagements